13/02/2018 15:22:33

TransPerfect Life Sciences Announces Release of Trial Interactive myTI Mobile eTMF Application

NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- TransPerfect Life Sciences, a leading provider of services and technologies to support clinical trials and product development for the biopharmaceutical industry, today announced the release of myTI, the company’s ground-breaking mobile application that enables real-time eTMF access and functionality for study teams on the go.

myTI is a mobile extension of Trial Interactive, TransPerfect’s award-winning cloud-based e-clinical technology designed by clinical professionals for clinical professionals to simplify management of product development, from study start up to commercialization.  myTI offers significant benefits to Trial Interactive users by placing key eTMF functionality at the fingertips of study teams no matter where they are. By taking these study processes mobile, including secure document capture, query resolution, and task management, myTI enables users to maximize TMF health and keep studies moving at all times.

Highlights of myTI include:

  •         Document Detection, Capture, and Submission: Securely capture and upload documents using your mobile device camera and a simple auto-capture interface that straightens and adjusts documents prior to PDF conversion and upload
  •         Query Resolution: Review documents with queries and resolve them within the mobile interface
  •         Document Status: View status, metadata, and update/re-submit expired documents from your phone or tablet
  •         Geolocation: Auto-populate site information based on document capture location
  •         Role Specific Access: Customized access levels can be set for CRAs, project managers, TMF leads, and other stakeholders.
  •         iPhone and iPad iOS: Versions 10.3+ with support back to model 5. Android version to release in Q2 2018
  •         Secure Touch ID® and Face ID® login: Secure and configurable for devices that support TouchID® or Face ID®
  •         CFR 21 Part 11 Compliant: Complies with regulatory standards for hosting eTMF documents

“By enabling a move away from archaic paper TMF management, mobile document capture and upload at investigative sites is a huge step forward in product development and for simplifying the significant project management and CRA challenges involved with bringing treatments to market,” said Michael Smyth, General Manager of TransPerfect Life Sciences Solutions. “myTI will equip study teams with on-the-go access to eTMF materials, which will cut lengthy upload timelines and allow filing with near real time availability, helping to expedite overall timelines and ensuring TMF inspection readiness.”

Demos for Trial Interactive myTI can be scheduled by emailing info@trialinteractive.com.

About Trial Interactive

TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit www.trialinteractive.com

About TransPerfect

TransPerfect is the world’s leading provider of language services and technology solutions for global business. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 4,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.

Contact:

Ryan Simper +1 212.689.5555

mediainquiry@transperfect.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
09 Aug
PNDORA
Pandora kom med ny guidance mandag og Q2-regnskab i dag torsdag.   Her den nye guidance fra i mandag..
57
09 Aug
PNDORA
Du er meget dygtig Portensafe...tillykke med det. Du er sådan et typisk dobbeltalias, som pludselig ..
27
10 Aug
PNDORA
Flere indlæg her på EI, viser i høj grad hvor forelskede, og desperate pandora investorene her på EI..
25
14 Aug
VELO
Vi har diskuteret markedet for immunosuppressive medikamenter før, og jeg har i et tidligere indlæg ..
22
13 Aug
VELO
Husk at markedet er gigantisk! Astellas' to produkter AstagrafXL og Prograf solgte for ca. 12 mia. k..
18
10 Aug
 
Hej Ketty99,   Efter min mening, så 'Ja' vi er overdue, men et aktiemarked kan typisk løbe længere o..
17
10 Aug
VWS
Jeg går ud fra den (måske fejlagtige) antagelse at hele 2018 produktionen allerede stod i ordrebogen..
17
09 Aug
PNDORA
EI smid den tosse Portensafe udfra sitet. Manden er fuldstændig ligegyldig. Tjek om det er en der sk..
17
15 Aug
VELO
Bare t.o. Jeg taler efter planen med Craig Collard i eftermiddag og sender en artikel ud i morgen.  ..
16
15 Aug
 
Endnu et fantast firma på First North...og denne gang med det flatterende navn Hypefactor...   Når m..
16

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Thinfilm and Clause Collaborate to Deliver NFC Technology to Blockchain Smart Legal Contracts
2
BIMobject AB: Interim Report April - June 2018
3
Corning Receives Frost & Sullivan's 2018 APAC Data Center Enabling Technology Leadership Award
4
AKVA group ASA: 2Q and 1H 2018 financial reporting
5
WISeKey Cybersecurity Growing by over 60% compared to same period last as more companies required ID Management to facilitate their compliance with GDPR

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 August 2018 05:01:42
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180815.6 - EUROWEB5 - 2018-08-16 06:01:42 - 2018-08-16 05:01:42 - 1000 - Website: OKAY